HomeCompareMLND vs PEP

MLND vs PEP: Dividend Comparison 2026

MLND yields 188.68% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLND wins by $85.40M in total portfolio value
10 years
MLND
MLND
● Live price
188.68%
Share price
$1.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$85.54M
Annual income
$41,878,852.89
Full MLND calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — MLND vs PEP

📍 MLND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLNDPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLND + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLND pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLND
Annual income on $10K today (after 15% tax)
$16,037.74/yr
After 10yr DRIP, annual income (after tax)
$35,597,024.96/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, MLND beats the other by $35,544,430.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLND + PEP for your $10,000?

MLND: 50%PEP: 50%
100% PEP50/50100% MLND
Portfolio after 10yr
$42.84M
Annual income
$20,970,364.28/yr
Blended yield
48.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

MLND
Analyst Ratings
3
Buy
3
Hold
Consensus: Buy
Altman Z
-18.3
Piotroski
4/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLND buys
0
PEP buys
0
No recent congressional trades found for MLND or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLNDPEP
Forward yield188.68%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$85.54M$141.9K
Annual income after 10y$41,878,852.89$61,875.67
Total dividends collected$80.35M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: MLND vs PEP ($10,000, DRIP)

YearMLND PortfolioMLND Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$29,568$18,867.92$10,849$509.42+$18.7KMLND
2$83,776$52,138.82$11,969$750.47+$71.8KMLND
3$227,704$138,063.47$13,500$1,124.14+$214.2KMLND
4$594,350$350,706.71$15,680$1,721.66+$578.7KMLND
5$1,491,478$855,522.69$18,929$2,715.34+$1.47MMLND
6$3,602,301$2,006,420.52$24,023$4,450.80+$3.58MMLND
7$8,383,454$4,528,991.67$32,510$7,669.92+$8.35MMLND
8$18,820,851$9,850,554.67$47,709$14,093.60+$18.77MMLND
9$40,806,058$20,667,748.07$77,415$28,083.48+$40.73MMLND
10$85,541,335$41,878,852.89$141,922$61,875.67+$85.40MMLND

MLND vs PEP: Complete Analysis 2026

MLNDStock

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

Full MLND Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this MLND vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLND vs SCHDMLND vs JEPIMLND vs OMLND vs KOMLND vs MAINMLND vs MOMLND vs PMMLND vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.